MAPFRE S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.226 EUR | +0.45% |
|
-5.12% | +14.57% |
| May. 08 | Spanish Insurer Mapfre Secures EUR15 Million Investment for Biomethane Fund | MT |
| Apr. 30 | MAPFRE : 2024 start similar to that of 2023 |  |
| Sales 2024 * | 29.24B 31.71B | Sales 2025 * | 30.23B 32.78B | Capitalization | 6.82B 7.4B |
|---|---|---|---|---|---|
| Net income 2024 * | 873M 947M | Net income 2025 * | 937M 1.02B | EV / Sales 2024 * | 0.23 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.23 x |
| P/E ratio 2024 * |
7.74
x | P/E ratio 2025 * |
7.21
x | Employees | 30,873 |
| Yield 2024 * |
7.2% | Yield 2025 * |
7.65% | Free-Float | 29.68% |
More Fundamentals
* Assessed data
More news
Latest transcript on Mapfre S.A.
More recommendations
More press releases
More news
| 1 day | +0.45% | ||
| 1 week | -5.12% | ||
| Current month | -1.59% | ||
| 1 month | -2.37% | ||
| 3 months | +13.05% | ||
| 6 months | +6.20% | ||
| Current year | +14.57% |
1 week
2.18
2.37
1 month
2.182.37
Current year
1.922.39
1 year
1.762.39
3 years
1.532.39
5 years
1.232.75
10 years
1.233.62
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 06-12-28 | |
| Director of Finance/CFO | 63 | 16-12-31 | |
| Chief Tech/Sci/R&D Officer | 45 | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 17-02-28 | |
| Director/Board Member | 59 | 19-09-25 | |
| Chief Executive Officer | 60 | 06-12-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.76% | 113 M€ | +11.35% | - | |
| 0.20% | 1,083 M€ | +4.23% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 2.226 | +0.45% | 2,741,208 |
| 24-05-23 | 2.216 | -1.07% | 2,384,411 |
| 24-05-22 | 2.24 | -5.08% | 3,921,653 |
| 24-05-21 | 2.36 | +0.17% | 5,402,476 |
| 24-05-20 | 2.356 | +0.43% | 2,459,663 |
Delayed Quote BME, May 24, 2024 at 11:35 am EDT
More quotes
Mapfre S.A. is an insurance group organized around three areas of activity:
- non-life insurance (63.5% of written premiums): automotive insurance (38.3% of written premiums), P&C insurance (26.7%), accident and health insurance (11.4%) and other (33.6%);
- life insurance (19.2%);
- reinsurance (17.3%).
At the end of 2021, products are marketed through a network of 15 354 branches located in Iberia (8,992), Latin America (5,914), Eurasia (420) and North America (28).
Revenues break down geographically as follows: Iberia (41.8%), Eurasia (7.4%), Brazil (18.4%), Latin America (20.9%), North America (10.9%) and other (0.6%).
Calendar
2024-05-27
- Foro Medcap Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
2.226
EUR
Average target price
2.456
EUR
Spread / Average Target
+10.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.57% | 7.4B | |
| +9.49% | 112B | |
| +17.15% | 111B | |
| +9.72% | 103B | |
| +6.92% | 74.04B | |
| +26.00% | 29.95B | |
| +12.76% | 20.42B | |
| -2.85% | 12.5B | |
| +7.26% | 11.16B | |
| +11.94% | 10.94B |
- Stock Market
- Equities
- MAP Stock
